Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ionis Pharmaceuticals is a biotech company specializing in RNA-targeted therapeutics. It develops and commercializes medicines for serious diseases across neurology, cardiology, and rare genetic disorders. Its core products include antisense and siRNA medicines, with a focus on genetic and neurodegenerative conditions. The company partners with global pharma firms, leveraging innovative technology to deliver life-changing treatments and generate revenue through product sales, royalties, and milestone payments.
This description was generated via AI from an annual report. Updated about 1 year ago.